anti glur1 antibody Search Results


95
Alomone Labs rabbit anti glua1
Rabbit Anti Glua1, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+glur1+antibody/Anti-GluR1+(GluA1)+(extracellular)+Antibody/pm24667327-230-4-17
Average 95 stars, based on 1 article reviews
rabbit anti glua1 - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

96
PhosphoSolutions glur1 ser 845
Figure 2. MCH acts via Gi/o to reduce <t>GluR1</t> pSer 845 in the AcbSh. Graphs represent the ratio of phosphorylated signal to total protein signal for all treatments. A, Basal or SKF 81297-mediated GluR1 pSer 845 reduction by MCH is blocked by in vivo PTX treatment (n 12–15 slices per group). B, MCH-mediated reduction is not affected by inhibition of PLC–PKC pathway with U73122 (n 5 slices per group). *p 0.05, **p 0.01. Error bars indicate SEM.
Glur1 Ser 845, supplied by PhosphoSolutions, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+glur1+antibody/Anti-GluR1+Antibody/10__1523_slash_jneurosci__5858___09__2010-59-15-23
Average 96 stars, based on 1 article reviews
glur1 ser 845 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
PhosphoSolutions ps831 glua1
Figure 2. MCH acts via Gi/o to reduce <t>GluR1</t> pSer 845 in the AcbSh. Graphs represent the ratio of phosphorylated signal to total protein signal for all treatments. A, Basal or SKF 81297-mediated GluR1 pSer 845 reduction by MCH is blocked by in vivo PTX treatment (n 12–15 slices per group). B, MCH-mediated reduction is not affected by inhibition of PLC–PKC pathway with U73122 (n 5 slices per group). *p 0.05, **p 0.01. Error bars indicate SEM.
Ps831 Glua1, supplied by PhosphoSolutions, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+glur1+antibody/Anti-GluR1-Subunit+(Ser831)+Antibody/pmc03038183-58-10-13
Average 96 stars, based on 1 article reviews
ps831 glua1 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
PhosphoSolutions glua1 ps831
Quantifications show means ± SEM. * P < 0.05 and ** P < 0.01. Scale bars, 10 μm. ( A ) Schematic of CaMKII movement in response excitatory LTD stimuli. The LTD-induced pT305/306 blocks CaMKII movement to glutamatergic excitatory synapses and instead enables movement to GABAergic inhibitory synapses. ( B ) cLTD stimulation increased surface GABA A R accumulation in WT, but not T305/6AV, CA1 mini-slices (unpaired two-tailed t test, P = 0.0033 for WT and P = 0.6760 for AV, n = 5 and 6 samples (two slices/sample), as detected by immunoblot after surface biotinylation. ( C ) cLTD stimulation decreased surface <t>GluA1</t> accumulation in WT, but not T305/6AV, CA1 mini-slices (unpaired two-tailed t test, P = 0.0062 for WT and P = 0.6252 for AV, n = 5 and 6 samples (two slices/sample). ( D ) cLTP decreased surface GABA A R cluster size in nonpermeabilized neurons from WT mouse hippocampal cultures (fixed 5 min after washout), while cLTD increased the cluster size (fixed 20 min after washout) (one-way ANOVA, Tukey’s post hoc test versus control, P = 0.0273 for cLTP and P = 0.0046 for cLTD; n = 12, 12, and 13 neurons), as detected by immunocytochemistry. ( E ) By contrast, in nonpermeabilized neurons from T305/5AV hippocampal cultures, cLTD did not increase surface GABA A R clusters. However, cLTP still decreased surface GABA A R clusters ( P = 0.0147 for cLTP and P = 0.7121 for cLTD; n = 15, 13, and 14 neurons).
Glua1 Ps831, supplied by PhosphoSolutions, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+glur1+antibody/Anti-GluR1-Subunit+(Ser845)+Antibody/pmc08046365-145-22-25
Average 96 stars, based on 1 article reviews
glua1 ps831 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

95
NeuroMab mouse anti glua1 antibody
Quantifications show means ± SEM. * P < 0.05 and ** P < 0.01. Scale bars, 10 μm. ( A ) Schematic of CaMKII movement in response excitatory LTD stimuli. The LTD-induced pT305/306 blocks CaMKII movement to glutamatergic excitatory synapses and instead enables movement to GABAergic inhibitory synapses. ( B ) cLTD stimulation increased surface GABA A R accumulation in WT, but not T305/6AV, CA1 mini-slices (unpaired two-tailed t test, P = 0.0033 for WT and P = 0.6760 for AV, n = 5 and 6 samples (two slices/sample), as detected by immunoblot after surface biotinylation. ( C ) cLTD stimulation decreased surface <t>GluA1</t> accumulation in WT, but not T305/6AV, CA1 mini-slices (unpaired two-tailed t test, P = 0.0062 for WT and P = 0.6252 for AV, n = 5 and 6 samples (two slices/sample). ( D ) cLTP decreased surface GABA A R cluster size in nonpermeabilized neurons from WT mouse hippocampal cultures (fixed 5 min after washout), while cLTD increased the cluster size (fixed 20 min after washout) (one-way ANOVA, Tukey’s post hoc test versus control, P = 0.0273 for cLTP and P = 0.0046 for cLTD; n = 12, 12, and 13 neurons), as detected by immunocytochemistry. ( E ) By contrast, in nonpermeabilized neurons from T305/5AV hippocampal cultures, cLTD did not increase surface GABA A R clusters. However, cLTP still decreased surface GABA A R clusters ( P = 0.0147 for cLTP and P = 0.7121 for cLTD; n = 15, 13, and 14 neurons).
Mouse Anti Glua1 Antibody, supplied by NeuroMab, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+glur1+antibody/Anti-GluA1-GluR1+Glutamate+Receptor+Antibody/pmc09753999-259-4-9
Average 95 stars, based on 1 article reviews
mouse anti glua1 antibody - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

93
Alomone Labs glua1
A) Western blot of GluAi and β-actin in cortical lysates of VKI mice (i) revealed no genotype effect on <t>GluA1</t> protein levels (ii). B) Co-immunoprecipitation of GluA1 with VPS35 (i) revealed no genotype effect (ii). C) Cultured cortical neurons immunostained for MAP2 (blue), VPS35 (cyan), and GluA1 (magenta)(i). There was a significant reduction in GluA1 cluster density in homozygous VKI neurons (ii, ** p <0.005), and no genotype effect on VPS35-GluAi co-cluster density of (iii), or Pearson’s coefficient (iv).
Glua1, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+glur1+antibody/Guinea+pig+Anti-GluR1+(GluA1)+(extracellular)+Antibody/bio_rxiv__2021__01__18__427223-246-50-51
Average 93 stars, based on 1 article reviews
glua1 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
Alomone Labs atto 594 red rabbit anti glua1 antibody
( A - C ) Surface biotinylation was used to isolate endogenous surface (s) <t>GluA1</t> and sGluA2 in acute striatal slices derived from wildtype (WT) and Lrrk2 G2019S (GS) mice. A ) Representative Western blot images of sGluA1, sGluA2, and actin from dataset quantified in B and C . Scatterplot/bar graphs plot values normalized to WT ± SEM (n = 7 - 8 mice/genotype, 3 slices/mouse). Unpaired t test *p= 0.0492, compared to WT. D ) Confocal image of DARPP32-labeled (white) co-cultured SPN (left) and super-resolution, STED images (right) of dendritic processes. Punctate sGluA1 (magenta), sGluA2 (green) labeling (tagged prior to permeabilization) associates largely, but not completed with PSD95 labeling (blue). E and F ) Violin plots compare surface AMPAR area ( E ) and intensity ( F ) within masks defined by PSD95 labeling in SPNs. Unpaired t test, ****p<0.0001; ***p<0.0001; Mann Whitney test *p=0.04. n= 3 preps and 15 ROIs/genotype.
Atto 594 Red Rabbit Anti Glua1 Antibody, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+glur1+antibody/Anti-GluR1+(GluA1)+(extracellular)-ATTO+Fluor-594+Antibody/bio_rxiv__2023__10__13__562231-168-7-13
Average 93 stars, based on 1 article reviews
atto 594 red rabbit anti glua1 antibody - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
Boster Bio glutamate receptor 2 glu2r
( A - C ) Surface biotinylation was used to isolate endogenous surface (s) <t>GluA1</t> and sGluA2 in acute striatal slices derived from wildtype (WT) and Lrrk2 G2019S (GS) mice. A ) Representative Western blot images of sGluA1, sGluA2, and actin from dataset quantified in B and C . Scatterplot/bar graphs plot values normalized to WT ± SEM (n = 7 - 8 mice/genotype, 3 slices/mouse). Unpaired t test *p= 0.0492, compared to WT. D ) Confocal image of DARPP32-labeled (white) co-cultured SPN (left) and super-resolution, STED images (right) of dendritic processes. Punctate sGluA1 (magenta), sGluA2 (green) labeling (tagged prior to permeabilization) associates largely, but not completed with PSD95 labeling (blue). E and F ) Violin plots compare surface AMPAR area ( E ) and intensity ( F ) within masks defined by PSD95 labeling in SPNs. Unpaired t test, ****p<0.0001; ***p<0.0001; Mann Whitney test *p=0.04. n= 3 preps and 15 ROIs/genotype.
Glutamate Receptor 2 Glu2r, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+glur1+antibody/Anti-Phospho-GluR1+(Ser845)+Gria1+Antibody/10__1155_slash_2024_slash_4784818-90-47-53
Average 93 stars, based on 1 article reviews
glutamate receptor 2 glu2r - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
Boster Bio anti phospho glur1 s845
( A - C ) Surface biotinylation was used to isolate endogenous surface (s) <t>GluA1</t> and sGluA2 in acute striatal slices derived from wildtype (WT) and Lrrk2 G2019S (GS) mice. A ) Representative Western blot images of sGluA1, sGluA2, and actin from dataset quantified in B and C . Scatterplot/bar graphs plot values normalized to WT ± SEM (n = 7 - 8 mice/genotype, 3 slices/mouse). Unpaired t test *p= 0.0492, compared to WT. D ) Confocal image of DARPP32-labeled (white) co-cultured SPN (left) and super-resolution, STED images (right) of dendritic processes. Punctate sGluA1 (magenta), sGluA2 (green) labeling (tagged prior to permeabilization) associates largely, but not completed with PSD95 labeling (blue). E and F ) Violin plots compare surface AMPAR area ( E ) and intensity ( F ) within masks defined by PSD95 labeling in SPNs. Unpaired t test, ****p<0.0001; ***p<0.0001; Mann Whitney test *p=0.04. n= 3 preps and 15 ROIs/genotype.
Anti Phospho Glur1 S845, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+glur1+antibody/Anti-GluR1+(Phospho-S845)+GRIA1+Antibody/pmc12259879-380-73-77
Average 93 stars, based on 1 article reviews
anti phospho glur1 s845 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

90
Boster Bio anti glur1 antibody
( A - C ) Surface biotinylation was used to isolate endogenous surface (s) <t>GluA1</t> and sGluA2 in acute striatal slices derived from wildtype (WT) and Lrrk2 G2019S (GS) mice. A ) Representative Western blot images of sGluA1, sGluA2, and actin from dataset quantified in B and C . Scatterplot/bar graphs plot values normalized to WT ± SEM (n = 7 - 8 mice/genotype, 3 slices/mouse). Unpaired t test *p= 0.0492, compared to WT. D ) Confocal image of DARPP32-labeled (white) co-cultured SPN (left) and super-resolution, STED images (right) of dendritic processes. Punctate sGluA1 (magenta), sGluA2 (green) labeling (tagged prior to permeabilization) associates largely, but not completed with PSD95 labeling (blue). E and F ) Violin plots compare surface AMPAR area ( E ) and intensity ( F ) within masks defined by PSD95 labeling in SPNs. Unpaired t test, ****p<0.0001; ***p<0.0001; Mann Whitney test *p=0.04. n= 3 preps and 15 ROIs/genotype.
Anti Glur1 Antibody, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+glur1+antibody/Anti-Glutamate+Receptor+1%2FGRIA1+Antibody+Picoband/pmc12259879-380-66-69
Average 90 stars, based on 1 article reviews
anti glur1 antibody - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Merck & Co glur1
Enhanced GABAergic tone from the NAc during conditioning to saline or cocaine decreases <t>GluA1</t> levels in the VTA. All rats were euthanized 45 min after the RePP test. Then, their VTA were taken out and homogenized. Samples were resolved by SDS-PAGE, and WB membranes were probed with the appropriate antibodies. (A) The bar histograms depict the level of ERK divided by Actin, and rats treated with cocaine (15 mg/kg) without optic stimulation, and rats treated with cocaine with optic stimulation displayed significantly lower values compared with the saline groups ( p < 0.05), as determined by a two-way ANOVA test [F OPTIC STIMULATION (1,10) = 5.746 , p < 0.05, F GROUP (1,10) = 45.24, p < 0.0001, F INTERACTION (1,10) = 0.8606, p > 0.05, followed by Tukey’s multiple comparison test]. ( n = 3 for the saline groups, n = 4 for the cocaine groups). (B) The bar histograms depict the level of pERK (Thr202/Tyr204) divided by ERK antibodies; no significant difference was found ( p > 0.05), as determined by a two-way ANOVA test [F OPTIC STIMULATION (1,10) = 1.515, p > 0.05, F GROUP (1,10) = 0.6789, p > 0.05, F INTERACTION (1,10) = 0.4926, p > 0.05, followed by Tukey’s multiple comparison test]. ( n = 3 for the saline groups, n = 4 for the cocaine groups). (C) The bar histograms depict the level of GluA1 divided by Actin, and rats treated with saline or cocaine with optic stimulation displayed significantly lower values compared with rats treated with saline or cocaine without optic stimulation ( p < 0.05), as determined by a two-way ANOVA test [F OPTIC STIMULATION (1,15) = 21.58, p < 0.001, F GROUP (1,15) = 0.1269, p > 0.05, F INTERACTION (1,15) = 0.1785, p > 0.05, followed by Tukey’s multiple comparison test]. ( n = 5, 4, 5, and 5 for saline -, saline +, cocaine-, and cocaine+ O.S. groups, respectively). (D) The bar histograms depict the level of GluA1ps845 divided by GluA1 antibodies, and no significant difference was found, as determined by a two-way ANOVA test [F OPTIC STIMULATION (1,10) = 2.936, p > 0.05, F GROUP (1,10) = 1.063, p > 0.05, F INTERACTION (1,10) = 0.00007179, p > 0.05, followed by Tukey’s multiple comparison test]. ( n = 3 for the saline groups, n = 4 for the cocaine groups). (E) The bar histograms depict the level of GluA1ps831 divided by GluA1 antibodies, and no significant difference was found, as determined by a two-way ANOVA test [F OPTIC STIMULATION (1,17) = 1.111, p > 0.05, F GROUP (1,17) = 0.8050, p > 0.05, F INTERACTION (1,17) = 0.7182, p > 0.05, followed by Tukey’s multiple comparison test]. ( n = 5, 4, 6, and 6 for saline -, saline +, cocaine-, and cocaine+ O.S. groups, respectively). (− O.S refers to - optic stimulation, whereas + O.S refers to + optic stimulation).
Glur1, supplied by Merck & Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+glur1+antibody/glur1/pmc10962329-97-25-30
Average 90 stars, based on 1 article reviews
glur1 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Merck KGaA anti-glur1 antibody pc246
Enhanced GABAergic tone from the NAc during conditioning to saline or cocaine decreases <t>GluA1</t> levels in the VTA. All rats were euthanized 45 min after the RePP test. Then, their VTA were taken out and homogenized. Samples were resolved by SDS-PAGE, and WB membranes were probed with the appropriate antibodies. (A) The bar histograms depict the level of ERK divided by Actin, and rats treated with cocaine (15 mg/kg) without optic stimulation, and rats treated with cocaine with optic stimulation displayed significantly lower values compared with the saline groups ( p < 0.05), as determined by a two-way ANOVA test [F OPTIC STIMULATION (1,10) = 5.746 , p < 0.05, F GROUP (1,10) = 45.24, p < 0.0001, F INTERACTION (1,10) = 0.8606, p > 0.05, followed by Tukey’s multiple comparison test]. ( n = 3 for the saline groups, n = 4 for the cocaine groups). (B) The bar histograms depict the level of pERK (Thr202/Tyr204) divided by ERK antibodies; no significant difference was found ( p > 0.05), as determined by a two-way ANOVA test [F OPTIC STIMULATION (1,10) = 1.515, p > 0.05, F GROUP (1,10) = 0.6789, p > 0.05, F INTERACTION (1,10) = 0.4926, p > 0.05, followed by Tukey’s multiple comparison test]. ( n = 3 for the saline groups, n = 4 for the cocaine groups). (C) The bar histograms depict the level of GluA1 divided by Actin, and rats treated with saline or cocaine with optic stimulation displayed significantly lower values compared with rats treated with saline or cocaine without optic stimulation ( p < 0.05), as determined by a two-way ANOVA test [F OPTIC STIMULATION (1,15) = 21.58, p < 0.001, F GROUP (1,15) = 0.1269, p > 0.05, F INTERACTION (1,15) = 0.1785, p > 0.05, followed by Tukey’s multiple comparison test]. ( n = 5, 4, 5, and 5 for saline -, saline +, cocaine-, and cocaine+ O.S. groups, respectively). (D) The bar histograms depict the level of GluA1ps845 divided by GluA1 antibodies, and no significant difference was found, as determined by a two-way ANOVA test [F OPTIC STIMULATION (1,10) = 2.936, p > 0.05, F GROUP (1,10) = 1.063, p > 0.05, F INTERACTION (1,10) = 0.00007179, p > 0.05, followed by Tukey’s multiple comparison test]. ( n = 3 for the saline groups, n = 4 for the cocaine groups). (E) The bar histograms depict the level of GluA1ps831 divided by GluA1 antibodies, and no significant difference was found, as determined by a two-way ANOVA test [F OPTIC STIMULATION (1,17) = 1.111, p > 0.05, F GROUP (1,17) = 0.8050, p > 0.05, F INTERACTION (1,17) = 0.7182, p > 0.05, followed by Tukey’s multiple comparison test]. ( n = 5, 4, 6, and 6 for saline -, saline +, cocaine-, and cocaine+ O.S. groups, respectively). (− O.S refers to - optic stimulation, whereas + O.S refers to + optic stimulation).
Anti Glur1 Antibody Pc246, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+glur1+antibody/anti+glur1+antibody+pc246/10__7554_slash_elife__29677-465-13-16
Average 90 stars, based on 1 article reviews
anti-glur1 antibody pc246 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


Figure 2. MCH acts via Gi/o to reduce GluR1 pSer 845 in the AcbSh. Graphs represent the ratio of phosphorylated signal to total protein signal for all treatments. A, Basal or SKF 81297-mediated GluR1 pSer 845 reduction by MCH is blocked by in vivo PTX treatment (n 12–15 slices per group). B, MCH-mediated reduction is not affected by inhibition of PLC–PKC pathway with U73122 (n 5 slices per group). *p 0.05, **p 0.01. Error bars indicate SEM.

Journal: Journal of Neuroscience

Article Title: Regulation of Nucleus Accumbens Activity by the Hypothalamic Neuropeptide Melanin-Concentrating Hormone

doi: 10.1523/jneurosci.5858-09.2010

Figure Lengend Snippet: Figure 2. MCH acts via Gi/o to reduce GluR1 pSer 845 in the AcbSh. Graphs represent the ratio of phosphorylated signal to total protein signal for all treatments. A, Basal or SKF 81297-mediated GluR1 pSer 845 reduction by MCH is blocked by in vivo PTX treatment (n 12–15 slices per group). B, MCH-mediated reduction is not affected by inhibition of PLC–PKC pathway with U73122 (n 5 slices per group). *p 0.05, **p 0.01. Error bars indicate SEM.

Article Snippet: For GluR1 protein detection, membranes were first blotted with the phospho-antibodies at 1:500 (rabbit polyclonal, GluR1 Ser 845 and Ser 831 antibodies from PhosphoSolutions).

Techniques: In Vivo, Inhibition

Figure4. SurfacelevelsofGluR1andmEPSCamplitudearereducedbyMCHinMSNsoftheAcbSh.A,Datarepresenttheratioof surface(cross-linked)tointernal(un-cross-linked)GluR1signal,andisnormalizedtountreatedcontrol.Treatmentconditionsare indicated below the graph along with representative surface and internal GluR1 signal (n 7–10 slices per group). B, C, Repre- sentativetracesbefore(B)andafter(C)bathapplicationofMCH(3M).D,E,Cumulativeprobabilityhistogramforamplitude(D) and interevent interval (E). n 8 neurons for mEPSC recordings; *p 0.05., **p 0.01. Error bars indicate SEM.

Journal: Journal of Neuroscience

Article Title: Regulation of Nucleus Accumbens Activity by the Hypothalamic Neuropeptide Melanin-Concentrating Hormone

doi: 10.1523/jneurosci.5858-09.2010

Figure Lengend Snippet: Figure4. SurfacelevelsofGluR1andmEPSCamplitudearereducedbyMCHinMSNsoftheAcbSh.A,Datarepresenttheratioof surface(cross-linked)tointernal(un-cross-linked)GluR1signal,andisnormalizedtountreatedcontrol.Treatmentconditionsare indicated below the graph along with representative surface and internal GluR1 signal (n 7–10 slices per group). B, C, Repre- sentativetracesbefore(B)andafter(C)bathapplicationofMCH(3M).D,E,Cumulativeprobabilityhistogramforamplitude(D) and interevent interval (E). n 8 neurons for mEPSC recordings; *p 0.05., **p 0.01. Error bars indicate SEM.

Article Snippet: For GluR1 protein detection, membranes were first blotted with the phospho-antibodies at 1:500 (rabbit polyclonal, GluR1 Ser 845 and Ser 831 antibodies from PhosphoSolutions).

Techniques:

Quantifications show means ± SEM. * P < 0.05 and ** P < 0.01. Scale bars, 10 μm. ( A ) Schematic of CaMKII movement in response excitatory LTD stimuli. The LTD-induced pT305/306 blocks CaMKII movement to glutamatergic excitatory synapses and instead enables movement to GABAergic inhibitory synapses. ( B ) cLTD stimulation increased surface GABA A R accumulation in WT, but not T305/6AV, CA1 mini-slices (unpaired two-tailed t test, P = 0.0033 for WT and P = 0.6760 for AV, n = 5 and 6 samples (two slices/sample), as detected by immunoblot after surface biotinylation. ( C ) cLTD stimulation decreased surface GluA1 accumulation in WT, but not T305/6AV, CA1 mini-slices (unpaired two-tailed t test, P = 0.0062 for WT and P = 0.6252 for AV, n = 5 and 6 samples (two slices/sample). ( D ) cLTP decreased surface GABA A R cluster size in nonpermeabilized neurons from WT mouse hippocampal cultures (fixed 5 min after washout), while cLTD increased the cluster size (fixed 20 min after washout) (one-way ANOVA, Tukey’s post hoc test versus control, P = 0.0273 for cLTP and P = 0.0046 for cLTD; n = 12, 12, and 13 neurons), as detected by immunocytochemistry. ( E ) By contrast, in nonpermeabilized neurons from T305/5AV hippocampal cultures, cLTD did not increase surface GABA A R clusters. However, cLTP still decreased surface GABA A R clusters ( P = 0.0147 for cLTP and P = 0.7121 for cLTD; n = 15, 13, and 14 neurons).

Journal: Science Advances

Article Title: CaMKII holoenzyme mechanisms that govern the LTP versus LTD decision

doi: 10.1126/sciadv.abe2300

Figure Lengend Snippet: Quantifications show means ± SEM. * P < 0.05 and ** P < 0.01. Scale bars, 10 μm. ( A ) Schematic of CaMKII movement in response excitatory LTD stimuli. The LTD-induced pT305/306 blocks CaMKII movement to glutamatergic excitatory synapses and instead enables movement to GABAergic inhibitory synapses. ( B ) cLTD stimulation increased surface GABA A R accumulation in WT, but not T305/6AV, CA1 mini-slices (unpaired two-tailed t test, P = 0.0033 for WT and P = 0.6760 for AV, n = 5 and 6 samples (two slices/sample), as detected by immunoblot after surface biotinylation. ( C ) cLTD stimulation decreased surface GluA1 accumulation in WT, but not T305/6AV, CA1 mini-slices (unpaired two-tailed t test, P = 0.0062 for WT and P = 0.6252 for AV, n = 5 and 6 samples (two slices/sample). ( D ) cLTP decreased surface GABA A R cluster size in nonpermeabilized neurons from WT mouse hippocampal cultures (fixed 5 min after washout), while cLTD increased the cluster size (fixed 20 min after washout) (one-way ANOVA, Tukey’s post hoc test versus control, P = 0.0273 for cLTP and P = 0.0046 for cLTD; n = 12, 12, and 13 neurons), as detected by immunocytochemistry. ( E ) By contrast, in nonpermeabilized neurons from T305/5AV hippocampal cultures, cLTD did not increase surface GABA A R clusters. However, cLTP still decreased surface GABA A R clusters ( P = 0.0147 for cLTP and P = 0.7121 for cLTD; n = 15, 13, and 14 neurons).

Article Snippet: The following antibodies were used: GABA A R α1 (1:1000; Synaptic Systems, 224 211), GluA1 (Millipore, AB1504), GluA1 pS845 (1:1000; PhosphoSolutions, p1160-845), GluA1 pS831 (1:1000, PhosphoSolutions, p1160-831), CaMKII pT286 (1:1000, PhosphoSolutions, p1005-286), CaMKII pT305 (1:800; Assay BioTech, A0005; but see fig. S2 and the note below), CaMKII pT306 (1:800; PhosphoSolutions, p1005-306), DAPK1 (1:1000; Sigma-Aldrich, D1319), DAPK1 pS308 (1:1000, Sigma-Aldrich, D4941), GluA1 pS567 (1:1000, provided by K. Roche) , and CaMKIIα (1:5000; CBα2, made in-house), 2° anti-rabbit (1:600; GE Healthcare, NA934V), anti-mouse secondary (1:10,000, GE Healthcare, NA931V), and Alexa Fluor 647 anti-mouse (1:5000; Molecular Probes, A21236).

Techniques: Two Tailed Test, Western Blot, Control, Immunocytochemistry

Quantifications show means ± SEM. ** P < 0.01. ( A ) Phosphorylation of the LTD-related GluA1 S567 site by pT286-CaMKII (10 nM kinase subunits) with Ca 2+ /CaM present [stimulated (Stim)] or absent [autonomous (Auton)]. No differences in pS567 were detected between autonomous versus stimulated targeting by either WT or T305/306AV (two-way ANOVA, Bonferroni post hoc test, P = 0.5249 for WT and P = 0.0730 for T305/306AV, n = 5 reactions), although the mutant showed a trend toward increased pS567 with autonomous activity. ( B ) Phosphorylation of the LTP-related GluA1 S831 site by pT286-CaMKII (10 nM kinase subunits) with Ca 2+ /CaM present (stimulated) or absent (autonomous). Enhanced pS831 under stimulated versus autonomous conditions was seen with CaMKII WT (two-way ANOVA, Bonferroni post hoc test, P = 0.0039, n = 5) but not with the T305/306AV mutant ( P = 0.7519, n = 5 reactions).

Journal: Science Advances

Article Title: CaMKII holoenzyme mechanisms that govern the LTP versus LTD decision

doi: 10.1126/sciadv.abe2300

Figure Lengend Snippet: Quantifications show means ± SEM. ** P < 0.01. ( A ) Phosphorylation of the LTD-related GluA1 S567 site by pT286-CaMKII (10 nM kinase subunits) with Ca 2+ /CaM present [stimulated (Stim)] or absent [autonomous (Auton)]. No differences in pS567 were detected between autonomous versus stimulated targeting by either WT or T305/306AV (two-way ANOVA, Bonferroni post hoc test, P = 0.5249 for WT and P = 0.0730 for T305/306AV, n = 5 reactions), although the mutant showed a trend toward increased pS567 with autonomous activity. ( B ) Phosphorylation of the LTP-related GluA1 S831 site by pT286-CaMKII (10 nM kinase subunits) with Ca 2+ /CaM present (stimulated) or absent (autonomous). Enhanced pS831 under stimulated versus autonomous conditions was seen with CaMKII WT (two-way ANOVA, Bonferroni post hoc test, P = 0.0039, n = 5) but not with the T305/306AV mutant ( P = 0.7519, n = 5 reactions).

Article Snippet: The following antibodies were used: GABA A R α1 (1:1000; Synaptic Systems, 224 211), GluA1 (Millipore, AB1504), GluA1 pS845 (1:1000; PhosphoSolutions, p1160-845), GluA1 pS831 (1:1000, PhosphoSolutions, p1160-831), CaMKII pT286 (1:1000, PhosphoSolutions, p1005-286), CaMKII pT305 (1:800; Assay BioTech, A0005; but see fig. S2 and the note below), CaMKII pT306 (1:800; PhosphoSolutions, p1005-306), DAPK1 (1:1000; Sigma-Aldrich, D1319), DAPK1 pS308 (1:1000, Sigma-Aldrich, D4941), GluA1 pS567 (1:1000, provided by K. Roche) , and CaMKIIα (1:5000; CBα2, made in-house), 2° anti-rabbit (1:600; GE Healthcare, NA934V), anti-mouse secondary (1:10,000, GE Healthcare, NA931V), and Alexa Fluor 647 anti-mouse (1:5000; Molecular Probes, A21236).

Techniques: Phospho-proteomics, Mutagenesis, Activity Assay

A) Western blot of GluAi and β-actin in cortical lysates of VKI mice (i) revealed no genotype effect on GluA1 protein levels (ii). B) Co-immunoprecipitation of GluA1 with VPS35 (i) revealed no genotype effect (ii). C) Cultured cortical neurons immunostained for MAP2 (blue), VPS35 (cyan), and GluA1 (magenta)(i). There was a significant reduction in GluA1 cluster density in homozygous VKI neurons (ii, ** p <0.005), and no genotype effect on VPS35-GluAi co-cluster density of (iii), or Pearson’s coefficient (iv).

Journal: bioRxiv

Article Title: Surface GluA1 and glutamatergic transmission are increased in cortical neurons of a VPS35 D620N knock-in mouse model of parkinsonism and altered by LRRK2 kinase inhibition

doi: 10.1101/2021.01.18.427223

Figure Lengend Snippet: A) Western blot of GluAi and β-actin in cortical lysates of VKI mice (i) revealed no genotype effect on GluA1 protein levels (ii). B) Co-immunoprecipitation of GluA1 with VPS35 (i) revealed no genotype effect (ii). C) Cultured cortical neurons immunostained for MAP2 (blue), VPS35 (cyan), and GluA1 (magenta)(i). There was a significant reduction in GluA1 cluster density in homozygous VKI neurons (ii, ** p <0.005), and no genotype effect on VPS35-GluAi co-cluster density of (iii), or Pearson’s coefficient (iv).

Article Snippet: We used the following primary antibodies: GFP (Abcam ab1218); VPS35 (Abnova H00055737); VPS26 (a kind gift from J. Bonifacino, NICHD); FAM21C (Millipore ABT79); NEEP21/NSG1 (Genscript A01442); Rab11 (Abcam ab95375); MAP2 (Abcam ab5392); GluA1 (Millipore 05-855R); PSD95 (Thermo Scientific MA1-045); VGluT1 (Millipore AB5905); GluA1 extracellular (Millipore ABN241); Rab10 (Abcam 237703); and GluA1 (Alomone AGP-009).

Techniques: Western Blot, Immunoprecipitation, Cell Culture

A) Western blot of cortical lysates and coIPs were probed for VPS35, D2R, GluA1, GluN1, GluA1, and GAPDH(i). There was no genotype effect on VPS35 levels or IP (ii-iii, 1-way ANOVA p >0.99; Kruskal-Wallis p =0.62, respectively). NMDA-receptor subunit GluN1 association with retromer has not previously been published; the mutation did not affect GluN1 levels nor coIP with VPS35 (iv-v, Kruskal-Wallis p =0.76; p =0.44, respectively). D2-type dopamine receptors are a novel cargo; there was no significant genotype effect on D2R levels or CoIP with VPS35 (vi-vii, Kruskal-Wallis p =0.80; p =0.44, respectively). B) CoIP of cortical lysates in A probed for LRRK2 (i). There were no significant genotype effects on LRRK2 levels or association of LRRK2 with VPS35 by coIP (ii-iii Kruskal-Wallis p =0.76; p =0.52, respectively). C) Striatal lysates quantified as in A & B (i). There were no genotype effects on VPS35 levels or pull by the antibody (ii-iii, Kruskal-Wallis p =0.97; p =0.13, respectively); GluN1 levels or coIP (iv-v, Kruskal-Wallis p =0.51; p =0.42, respectively); D2R levels or coIP (vi-vii Kruskal-Wallis p =0.70; p =0.45, respectively); GluA1 levels or coIP (viii-ix, Kruskal-Wallis p =0.83; p =0.44, respectively); or LRRK2 levels or coIP (x-xi, Kruskal-Wallis p >0.99; p =0.40, respectively). For all panels, n= number of experimental animals.

Journal: bioRxiv

Article Title: Surface GluA1 and glutamatergic transmission are increased in cortical neurons of a VPS35 D620N knock-in mouse model of parkinsonism and altered by LRRK2 kinase inhibition

doi: 10.1101/2021.01.18.427223

Figure Lengend Snippet: A) Western blot of cortical lysates and coIPs were probed for VPS35, D2R, GluA1, GluN1, GluA1, and GAPDH(i). There was no genotype effect on VPS35 levels or IP (ii-iii, 1-way ANOVA p >0.99; Kruskal-Wallis p =0.62, respectively). NMDA-receptor subunit GluN1 association with retromer has not previously been published; the mutation did not affect GluN1 levels nor coIP with VPS35 (iv-v, Kruskal-Wallis p =0.76; p =0.44, respectively). D2-type dopamine receptors are a novel cargo; there was no significant genotype effect on D2R levels or CoIP with VPS35 (vi-vii, Kruskal-Wallis p =0.80; p =0.44, respectively). B) CoIP of cortical lysates in A probed for LRRK2 (i). There were no significant genotype effects on LRRK2 levels or association of LRRK2 with VPS35 by coIP (ii-iii Kruskal-Wallis p =0.76; p =0.52, respectively). C) Striatal lysates quantified as in A & B (i). There were no genotype effects on VPS35 levels or pull by the antibody (ii-iii, Kruskal-Wallis p =0.97; p =0.13, respectively); GluN1 levels or coIP (iv-v, Kruskal-Wallis p =0.51; p =0.42, respectively); D2R levels or coIP (vi-vii Kruskal-Wallis p =0.70; p =0.45, respectively); GluA1 levels or coIP (viii-ix, Kruskal-Wallis p =0.83; p =0.44, respectively); or LRRK2 levels or coIP (x-xi, Kruskal-Wallis p >0.99; p =0.40, respectively). For all panels, n= number of experimental animals.

Article Snippet: We used the following primary antibodies: GFP (Abcam ab1218); VPS35 (Abnova H00055737); VPS26 (a kind gift from J. Bonifacino, NICHD); FAM21C (Millipore ABT79); NEEP21/NSG1 (Genscript A01442); Rab11 (Abcam ab95375); MAP2 (Abcam ab5392); GluA1 (Millipore 05-855R); PSD95 (Thermo Scientific MA1-045); VGluT1 (Millipore AB5905); GluA1 extracellular (Millipore ABN241); Rab10 (Abcam 237703); and GluA1 (Alomone AGP-009).

Techniques: Western Blot, Mutagenesis

A) Cultured cortical neurons immunostained for PSD95 (cyan) and VGluT1 (magenta) (i). There was no genotype effect on synapse density defined as VGluT1-PSD95 co-clusters (ii), nor on PSD95 or VGluT1 density (iii-iv).VGluT1 cluster intensity was significantly reduced in homozygous cells (v, ** p <0.003). B) Representative traces from whole-cell patch voltage clamp recording of mEPSCs in cortical neurons (i). There were significant genotype effects on mean mEPSC frequency (Hz) due to increases in heterozygous cells (ii, * p <0.02). Significant genotype effects were also seen in mEPSC amplitudes due to increases in heterozygous cells (iii, * p <0.02). Mean mEPSC decay times (τ) were not affected by genotype (iv). Representative mean-variance plots of mEPSC amplitude used for peak-scaled non-stationary fluctuation analysis, allowing calculation of single channel conductance (i). There was no significant effect of genotype on single channel conductance (vi, Kruskal-Wallis p =0.78). C) GFP-filled (cyan) cultured cortical cells immunostained for MAP2 (blue; to ensure no permeabilization) and surface GluAi (magenta)(i, left panel); in silico neurite outlines with only GluA1 staining displayed (i, right panel). There was a significant genotype effect on surface GluA1 cluster intensity (synaptic GluA1) due to significant increases in heterozygous cells (ii, ** p <0.02). There was a significant genotype effect on GluA1 cluster density, due to opposing effects on heterozygous and homozygous cells (iii, * p <0.05).

Journal: bioRxiv

Article Title: Surface GluA1 and glutamatergic transmission are increased in cortical neurons of a VPS35 D620N knock-in mouse model of parkinsonism and altered by LRRK2 kinase inhibition

doi: 10.1101/2021.01.18.427223

Figure Lengend Snippet: A) Cultured cortical neurons immunostained for PSD95 (cyan) and VGluT1 (magenta) (i). There was no genotype effect on synapse density defined as VGluT1-PSD95 co-clusters (ii), nor on PSD95 or VGluT1 density (iii-iv).VGluT1 cluster intensity was significantly reduced in homozygous cells (v, ** p <0.003). B) Representative traces from whole-cell patch voltage clamp recording of mEPSCs in cortical neurons (i). There were significant genotype effects on mean mEPSC frequency (Hz) due to increases in heterozygous cells (ii, * p <0.02). Significant genotype effects were also seen in mEPSC amplitudes due to increases in heterozygous cells (iii, * p <0.02). Mean mEPSC decay times (τ) were not affected by genotype (iv). Representative mean-variance plots of mEPSC amplitude used for peak-scaled non-stationary fluctuation analysis, allowing calculation of single channel conductance (i). There was no significant effect of genotype on single channel conductance (vi, Kruskal-Wallis p =0.78). C) GFP-filled (cyan) cultured cortical cells immunostained for MAP2 (blue; to ensure no permeabilization) and surface GluAi (magenta)(i, left panel); in silico neurite outlines with only GluA1 staining displayed (i, right panel). There was a significant genotype effect on surface GluA1 cluster intensity (synaptic GluA1) due to significant increases in heterozygous cells (ii, ** p <0.02). There was a significant genotype effect on GluA1 cluster density, due to opposing effects on heterozygous and homozygous cells (iii, * p <0.05).

Article Snippet: We used the following primary antibodies: GFP (Abcam ab1218); VPS35 (Abnova H00055737); VPS26 (a kind gift from J. Bonifacino, NICHD); FAM21C (Millipore ABT79); NEEP21/NSG1 (Genscript A01442); Rab11 (Abcam ab95375); MAP2 (Abcam ab5392); GluA1 (Millipore 05-855R); PSD95 (Thermo Scientific MA1-045); VGluT1 (Millipore AB5905); GluA1 extracellular (Millipore ABN241); Rab10 (Abcam 237703); and GluA1 (Alomone AGP-009).

Techniques: Cell Culture, In Silico, Staining

A) Western blot of whole brain lysate following acute MLi-2 treatment were probed for LRRK2, LRRK2 phospho-S935, GluA1, VPS35, VGluTl, Rab10, Rab10 phospho-T73, and β-actin. B) There were no significant effects of genotype or treatment on LRRK2 levels (2-way ANOVA genotype x treatment p =0.93; genotype p =0.90; treatment p =0.24). C) ML12 treatment significantly reduced pLRRK2 in all genotypes (2-way ANOVA treatment p <0.0001; Uncorrected Fisher’s LSD WT-WTMLi2 **** p <0.0001; Het-HetMLi2 *** p <0.0002; Ho-HoMLi2 **** p <0.0001). D-E) There was similarly no effect of genotype or treatment on Rab10 protein levels (D, 2-way ANOVA genotype x treatment p =0.5258; genotype p =0.4683; treatment p =0.9659), but significant genotype and treatment effects on pRab10 due to significant reductions in homozygous cells (E, 2-way ANOVA genotype p =0.04; treatment p <0.009; Uncorrected Fisher’s LSD WT-WTMLi2 p =0.82; Het-HetMLi2 p =0.10; Ho-HoMLi2 ** p =0.007). F-H) There were no significant effects of genotype or treatment on protein levels of VPS35 (F, 2-way ANOVA interaction p =0.23; genotype p =0.94; treatment p =0.89), VGluT1 (G, 2-way ANOVA interaction p =0.55; genotype p =0.39; treatment p =0.69), or GluA1 (H, 2-way ANOVA interaction p =0.45; genotype p =0.61; treatment p >0.99). For all experiments, n represents number of experimental animals and are as follows: WTCap n=5, WTMLi2 n=6, HetCap n=6, HetMLi2 n=6, HoCap n=5, HoMLi2 n=5.

Journal: bioRxiv

Article Title: Surface GluA1 and glutamatergic transmission are increased in cortical neurons of a VPS35 D620N knock-in mouse model of parkinsonism and altered by LRRK2 kinase inhibition

doi: 10.1101/2021.01.18.427223

Figure Lengend Snippet: A) Western blot of whole brain lysate following acute MLi-2 treatment were probed for LRRK2, LRRK2 phospho-S935, GluA1, VPS35, VGluTl, Rab10, Rab10 phospho-T73, and β-actin. B) There were no significant effects of genotype or treatment on LRRK2 levels (2-way ANOVA genotype x treatment p =0.93; genotype p =0.90; treatment p =0.24). C) ML12 treatment significantly reduced pLRRK2 in all genotypes (2-way ANOVA treatment p <0.0001; Uncorrected Fisher’s LSD WT-WTMLi2 **** p <0.0001; Het-HetMLi2 *** p <0.0002; Ho-HoMLi2 **** p <0.0001). D-E) There was similarly no effect of genotype or treatment on Rab10 protein levels (D, 2-way ANOVA genotype x treatment p =0.5258; genotype p =0.4683; treatment p =0.9659), but significant genotype and treatment effects on pRab10 due to significant reductions in homozygous cells (E, 2-way ANOVA genotype p =0.04; treatment p <0.009; Uncorrected Fisher’s LSD WT-WTMLi2 p =0.82; Het-HetMLi2 p =0.10; Ho-HoMLi2 ** p =0.007). F-H) There were no significant effects of genotype or treatment on protein levels of VPS35 (F, 2-way ANOVA interaction p =0.23; genotype p =0.94; treatment p =0.89), VGluT1 (G, 2-way ANOVA interaction p =0.55; genotype p =0.39; treatment p =0.69), or GluA1 (H, 2-way ANOVA interaction p =0.45; genotype p =0.61; treatment p >0.99). For all experiments, n represents number of experimental animals and are as follows: WTCap n=5, WTMLi2 n=6, HetCap n=6, HetMLi2 n=6, HoCap n=5, HoMLi2 n=5.

Article Snippet: We used the following primary antibodies: GFP (Abcam ab1218); VPS35 (Abnova H00055737); VPS26 (a kind gift from J. Bonifacino, NICHD); FAM21C (Millipore ABT79); NEEP21/NSG1 (Genscript A01442); Rab11 (Abcam ab95375); MAP2 (Abcam ab5392); GluA1 (Millipore 05-855R); PSD95 (Thermo Scientific MA1-045); VGluT1 (Millipore AB5905); GluA1 extracellular (Millipore ABN241); Rab10 (Abcam 237703); and GluA1 (Alomone AGP-009).

Techniques: Western Blot

A) Cultured cortical neurons immunostained for MAP2 (blue), PSD95 (cyan), and VGluT1 (magenta) following acute MLi-2 or vehicle treatment (i). There were interaction effects on PSD95 density due to increases in PSD95 density in heterozygous controls over WT (ii, *p<0.05) and a reduction in heterozygous neurons treated with MLi-2 *p<0.04. There were also interaction effects on VGluT1 density due to a reduction in cluster density in homozygous cells following MLi-2 treatment (iii, * p =0.03); however, there were no statistically significant effects on synapse (PSD95-VGluT1 co-cluster) density (iv). B) Non-permeabilized cultured cortical cells immunostained for MAP2 (blue), and surface GluA1 (magenta) following acute MLi-2 or vehicle treatment (i). There was a significant interaction effect on surface GluA1 cluster density (ii) due to an increase in WT surface GlulA1 clusters (** p <0.004); There was a significant interaction effect on surface GluA1 intensity (iii), though in this case it was due to underlying differences in control heterozygous and homozygous cells (*** p <0.0004) and a treatment effect in homozygous cells (** p <0.004). Normalization of treatment effects within genotype revealed that changes to GluA1 surface density (iv) were significantly larger in WT cells than heterozygous (** p <0.003) and homozygous mutant cells (**** p <0.0001), and that treatment had opposite effects on GluA1 intensity (v) in heterozygous cells than it did in WT (* p <0.02) and homozygous cells (* p <0.02). For Aii-v, n=40(4) for all groups and for Bii-iii, n=30(3).

Journal: bioRxiv

Article Title: Surface GluA1 and glutamatergic transmission are increased in cortical neurons of a VPS35 D620N knock-in mouse model of parkinsonism and altered by LRRK2 kinase inhibition

doi: 10.1101/2021.01.18.427223

Figure Lengend Snippet: A) Cultured cortical neurons immunostained for MAP2 (blue), PSD95 (cyan), and VGluT1 (magenta) following acute MLi-2 or vehicle treatment (i). There were interaction effects on PSD95 density due to increases in PSD95 density in heterozygous controls over WT (ii, *p<0.05) and a reduction in heterozygous neurons treated with MLi-2 *p<0.04. There were also interaction effects on VGluT1 density due to a reduction in cluster density in homozygous cells following MLi-2 treatment (iii, * p =0.03); however, there were no statistically significant effects on synapse (PSD95-VGluT1 co-cluster) density (iv). B) Non-permeabilized cultured cortical cells immunostained for MAP2 (blue), and surface GluA1 (magenta) following acute MLi-2 or vehicle treatment (i). There was a significant interaction effect on surface GluA1 cluster density (ii) due to an increase in WT surface GlulA1 clusters (** p <0.004); There was a significant interaction effect on surface GluA1 intensity (iii), though in this case it was due to underlying differences in control heterozygous and homozygous cells (*** p <0.0004) and a treatment effect in homozygous cells (** p <0.004). Normalization of treatment effects within genotype revealed that changes to GluA1 surface density (iv) were significantly larger in WT cells than heterozygous (** p <0.003) and homozygous mutant cells (**** p <0.0001), and that treatment had opposite effects on GluA1 intensity (v) in heterozygous cells than it did in WT (* p <0.02) and homozygous cells (* p <0.02). For Aii-v, n=40(4) for all groups and for Bii-iii, n=30(3).

Article Snippet: We used the following primary antibodies: GFP (Abcam ab1218); VPS35 (Abnova H00055737); VPS26 (a kind gift from J. Bonifacino, NICHD); FAM21C (Millipore ABT79); NEEP21/NSG1 (Genscript A01442); Rab11 (Abcam ab95375); MAP2 (Abcam ab5392); GluA1 (Millipore 05-855R); PSD95 (Thermo Scientific MA1-045); VGluT1 (Millipore AB5905); GluA1 extracellular (Millipore ABN241); Rab10 (Abcam 237703); and GluA1 (Alomone AGP-009).

Techniques: Cell Culture, Mutagenesis

A) There was no genotype effect on Rab10 cluster intensity (i); however, Rab10 cluster density was increased in both mutant genotypes, falling just shy of statistical significance (ii, p <0.06). B) GFP-filled (blue) cortical neurons immunostained for Rab10 (magenta), and VPS35 (cyan)(i). There were no genotype effects on co-cluster density (ii) or Pearson’s coefficient (ii). C) GFP-filled (blue) cortical neurons immunostained for Rab10 (magenta), and GluA1 (cyan)(i). There were no genotype effects on co-cluster density or Pearson’s coefficient (ii-iii).

Journal: bioRxiv

Article Title: Surface GluA1 and glutamatergic transmission are increased in cortical neurons of a VPS35 D620N knock-in mouse model of parkinsonism and altered by LRRK2 kinase inhibition

doi: 10.1101/2021.01.18.427223

Figure Lengend Snippet: A) There was no genotype effect on Rab10 cluster intensity (i); however, Rab10 cluster density was increased in both mutant genotypes, falling just shy of statistical significance (ii, p <0.06). B) GFP-filled (blue) cortical neurons immunostained for Rab10 (magenta), and VPS35 (cyan)(i). There were no genotype effects on co-cluster density (ii) or Pearson’s coefficient (ii). C) GFP-filled (blue) cortical neurons immunostained for Rab10 (magenta), and GluA1 (cyan)(i). There were no genotype effects on co-cluster density or Pearson’s coefficient (ii-iii).

Article Snippet: We used the following primary antibodies: GFP (Abcam ab1218); VPS35 (Abnova H00055737); VPS26 (a kind gift from J. Bonifacino, NICHD); FAM21C (Millipore ABT79); NEEP21/NSG1 (Genscript A01442); Rab11 (Abcam ab95375); MAP2 (Abcam ab5392); GluA1 (Millipore 05-855R); PSD95 (Thermo Scientific MA1-045); VGluT1 (Millipore AB5905); GluA1 extracellular (Millipore ABN241); Rab10 (Abcam 237703); and GluA1 (Alomone AGP-009).

Techniques: Mutagenesis

( A - C ) Surface biotinylation was used to isolate endogenous surface (s) GluA1 and sGluA2 in acute striatal slices derived from wildtype (WT) and Lrrk2 G2019S (GS) mice. A ) Representative Western blot images of sGluA1, sGluA2, and actin from dataset quantified in B and C . Scatterplot/bar graphs plot values normalized to WT ± SEM (n = 7 - 8 mice/genotype, 3 slices/mouse). Unpaired t test *p= 0.0492, compared to WT. D ) Confocal image of DARPP32-labeled (white) co-cultured SPN (left) and super-resolution, STED images (right) of dendritic processes. Punctate sGluA1 (magenta), sGluA2 (green) labeling (tagged prior to permeabilization) associates largely, but not completed with PSD95 labeling (blue). E and F ) Violin plots compare surface AMPAR area ( E ) and intensity ( F ) within masks defined by PSD95 labeling in SPNs. Unpaired t test, ****p<0.0001; ***p<0.0001; Mann Whitney test *p=0.04. n= 3 preps and 15 ROIs/genotype.

Journal: bioRxiv

Article Title: Parkinson’s-linked LRRK2-G2019S derails AMPAR trafficking, mobility and composition in striatum with cell-type and subunit specificity

doi: 10.1101/2023.10.13.562231

Figure Lengend Snippet: ( A - C ) Surface biotinylation was used to isolate endogenous surface (s) GluA1 and sGluA2 in acute striatal slices derived from wildtype (WT) and Lrrk2 G2019S (GS) mice. A ) Representative Western blot images of sGluA1, sGluA2, and actin from dataset quantified in B and C . Scatterplot/bar graphs plot values normalized to WT ± SEM (n = 7 - 8 mice/genotype, 3 slices/mouse). Unpaired t test *p= 0.0492, compared to WT. D ) Confocal image of DARPP32-labeled (white) co-cultured SPN (left) and super-resolution, STED images (right) of dendritic processes. Punctate sGluA1 (magenta), sGluA2 (green) labeling (tagged prior to permeabilization) associates largely, but not completed with PSD95 labeling (blue). E and F ) Violin plots compare surface AMPAR area ( E ) and intensity ( F ) within masks defined by PSD95 labeling in SPNs. Unpaired t test, ****p<0.0001; ***p<0.0001; Mann Whitney test *p=0.04. n= 3 preps and 15 ROIs/genotype.

Article Snippet: Cultured neurons were live-labeled with a direct-conjugated, ATTO-594 (red) rabbit anti-GluA1 antibody (1:100, Alomone AGC-004-AR, RRID:AB_2340944) for 15 min at room temperature.

Techniques: Biotinylation, Derivative Assay, Western Blot, Confocal, Labeling, Cell Culture, Super Resolution, MANN-WHITNEY, Immunofluorescence

A ) Schematic outlines antibody feeding assay used to monitor GluA1 internalization in wildtype (WT) and Lrrk2 G2019S (GS) corticostriatal co-cultures (DIV16-18) and serves as a key for the colors used to show data. B and C ) Overlay images show labeled surface (s) GluA1 (green mask + red mask) and internalized (i) GluA1 (red mask only) signal contained within DARPP-32 labeled SPNs (shown at a reduced intensity to permit visualization of puncta. Masks were generated in Image J and magnification is shown in B. D - G ) Intensity distribution of green and red labeling along a 60 µm line scan. H ) Quantification of the internalization index of GluA1 receptors in WT and GS SPNs at 0 and 60 min (n = 12 - 16 cells, 3 preps/genotype). Two-way ANOVA (F ( , ) = 9.809, p = 0.0029), post hoc Šidák test **p = 0.0049.

Journal: bioRxiv

Article Title: Parkinson’s-linked LRRK2-G2019S derails AMPAR trafficking, mobility and composition in striatum with cell-type and subunit specificity

doi: 10.1101/2023.10.13.562231

Figure Lengend Snippet: A ) Schematic outlines antibody feeding assay used to monitor GluA1 internalization in wildtype (WT) and Lrrk2 G2019S (GS) corticostriatal co-cultures (DIV16-18) and serves as a key for the colors used to show data. B and C ) Overlay images show labeled surface (s) GluA1 (green mask + red mask) and internalized (i) GluA1 (red mask only) signal contained within DARPP-32 labeled SPNs (shown at a reduced intensity to permit visualization of puncta. Masks were generated in Image J and magnification is shown in B. D - G ) Intensity distribution of green and red labeling along a 60 µm line scan. H ) Quantification of the internalization index of GluA1 receptors in WT and GS SPNs at 0 and 60 min (n = 12 - 16 cells, 3 preps/genotype). Two-way ANOVA (F ( , ) = 9.809, p = 0.0029), post hoc Šidák test **p = 0.0049.

Article Snippet: Cultured neurons were live-labeled with a direct-conjugated, ATTO-594 (red) rabbit anti-GluA1 antibody (1:100, Alomone AGC-004-AR, RRID:AB_2340944) for 15 min at room temperature.

Techniques: Feeding Assay, Co-Cultures, Labeling, Generated, Immunofluorescence

A, C ) Bar graph/scatterplots comparing functional contribution of CP-AMPARs using ratios of EPSCs evoked in the presence/absence of NASPM in D 1 R ( A; Drd1tdTom+ ) and D 2 R ( C; Drd1tdTom- ) SPNs in WT and GS mice (P70 - P90) in acute slices through dorsal striatum. Bars are mean ± SEM (n = 11 cells, 5 - 6 mice/group, unpaired t test *p = 0.0122). Example traces ( B ) show AMPAR currents before (black) and after (lavender) bath application of NASPM (200µM, 10 min). D - G , Superresolution (tau-STED) images ( D, E ) and quantification ( F, G ) of synaptic and extrasynaptic receptors in 21 DIV WT and GS D 1 R SPNs expressing tdTomato (white, Drd1 Cre/+; Ai14 , in D, E, and used to segment D1R SPNs for F, G) and co-cultured with unlabeled cortical neurons of the same genotype. sGluA1 ( D , magenta, STED) and sGluA2 ( E , green, STED) puncta in relation to PSD95 labeled postsynaptic sites (blue, confocal). Circled zones are enlarged in the center panels. F, G ) Bar graph/scatterplots show synaptic ( F , within a mask defined by PSD95) and extrasynaptic ( G , outside a PSD95 mask) sGluA1 (lavender) and sGluA2 (green) nanoclusters in D 1 R SPNs. F : Unpaired t test **p = 0.0369; n = 16 ROIs/genotype). G : Unpaired t test ****p<0.0001; n = 16 ROIs/genotype. H - K ) Examples ( H ) and quantification ( I - K ) of FRAP experiments. (H) Time lapse confocal images pre- and postphotobleaching (dotted circles approximate ROIs) in WT and GS D 1 R SPNs labeled and co-cultured as above. Table ( I ) compares time constant, diffusion (D) and % mobile receptors. D was calculated using: D = 0.25 (r 2 /τ 1/2 ), where r refers to the bleach radius and τ 1/2 to the time constant 46 . Graph ( J ) plots normalized SEP-GluA1 fluorescence recov-ery in WT and GS neurons imaged every 2.5 s. Lighter shading is ± SEM. Two-way RM-ANOVA (F(89, 3115) = 17.79, **p < 0.001, n = 19-20 spines/genotype. Scatterplot ( K ) compares recovery of SEP-GluA1 intensity at T222.5 s time point relative to post-bleach in WT and GS D 1 R SPNs. One-way ANOVA (F(3, 70) = 24.15, p < 0.0001), post hoc Tukey’s multiple comparison test ****p<0.0001.

Journal: bioRxiv

Article Title: Parkinson’s-linked LRRK2-G2019S derails AMPAR trafficking, mobility and composition in striatum with cell-type and subunit specificity

doi: 10.1101/2023.10.13.562231

Figure Lengend Snippet: A, C ) Bar graph/scatterplots comparing functional contribution of CP-AMPARs using ratios of EPSCs evoked in the presence/absence of NASPM in D 1 R ( A; Drd1tdTom+ ) and D 2 R ( C; Drd1tdTom- ) SPNs in WT and GS mice (P70 - P90) in acute slices through dorsal striatum. Bars are mean ± SEM (n = 11 cells, 5 - 6 mice/group, unpaired t test *p = 0.0122). Example traces ( B ) show AMPAR currents before (black) and after (lavender) bath application of NASPM (200µM, 10 min). D - G , Superresolution (tau-STED) images ( D, E ) and quantification ( F, G ) of synaptic and extrasynaptic receptors in 21 DIV WT and GS D 1 R SPNs expressing tdTomato (white, Drd1 Cre/+; Ai14 , in D, E, and used to segment D1R SPNs for F, G) and co-cultured with unlabeled cortical neurons of the same genotype. sGluA1 ( D , magenta, STED) and sGluA2 ( E , green, STED) puncta in relation to PSD95 labeled postsynaptic sites (blue, confocal). Circled zones are enlarged in the center panels. F, G ) Bar graph/scatterplots show synaptic ( F , within a mask defined by PSD95) and extrasynaptic ( G , outside a PSD95 mask) sGluA1 (lavender) and sGluA2 (green) nanoclusters in D 1 R SPNs. F : Unpaired t test **p = 0.0369; n = 16 ROIs/genotype). G : Unpaired t test ****p<0.0001; n = 16 ROIs/genotype. H - K ) Examples ( H ) and quantification ( I - K ) of FRAP experiments. (H) Time lapse confocal images pre- and postphotobleaching (dotted circles approximate ROIs) in WT and GS D 1 R SPNs labeled and co-cultured as above. Table ( I ) compares time constant, diffusion (D) and % mobile receptors. D was calculated using: D = 0.25 (r 2 /τ 1/2 ), where r refers to the bleach radius and τ 1/2 to the time constant 46 . Graph ( J ) plots normalized SEP-GluA1 fluorescence recov-ery in WT and GS neurons imaged every 2.5 s. Lighter shading is ± SEM. Two-way RM-ANOVA (F(89, 3115) = 17.79, **p < 0.001, n = 19-20 spines/genotype. Scatterplot ( K ) compares recovery of SEP-GluA1 intensity at T222.5 s time point relative to post-bleach in WT and GS D 1 R SPNs. One-way ANOVA (F(3, 70) = 24.15, p < 0.0001), post hoc Tukey’s multiple comparison test ****p<0.0001.

Article Snippet: Cultured neurons were live-labeled with a direct-conjugated, ATTO-594 (red) rabbit anti-GluA1 antibody (1:100, Alomone AGC-004-AR, RRID:AB_2340944) for 15 min at room temperature.

Techniques: Functional Assay, Expressing, Cell Culture, Labeling, Confocal, Diffusion-based Assay, Fluorescence, Comparison, Immunofluorescence, Western Blot, Patch Clamp

Enhanced GABAergic tone from the NAc during conditioning to saline or cocaine decreases GluA1 levels in the VTA. All rats were euthanized 45 min after the RePP test. Then, their VTA were taken out and homogenized. Samples were resolved by SDS-PAGE, and WB membranes were probed with the appropriate antibodies. (A) The bar histograms depict the level of ERK divided by Actin, and rats treated with cocaine (15 mg/kg) without optic stimulation, and rats treated with cocaine with optic stimulation displayed significantly lower values compared with the saline groups ( p < 0.05), as determined by a two-way ANOVA test [F OPTIC STIMULATION (1,10) = 5.746 , p < 0.05, F GROUP (1,10) = 45.24, p < 0.0001, F INTERACTION (1,10) = 0.8606, p > 0.05, followed by Tukey’s multiple comparison test]. ( n = 3 for the saline groups, n = 4 for the cocaine groups). (B) The bar histograms depict the level of pERK (Thr202/Tyr204) divided by ERK antibodies; no significant difference was found ( p > 0.05), as determined by a two-way ANOVA test [F OPTIC STIMULATION (1,10) = 1.515, p > 0.05, F GROUP (1,10) = 0.6789, p > 0.05, F INTERACTION (1,10) = 0.4926, p > 0.05, followed by Tukey’s multiple comparison test]. ( n = 3 for the saline groups, n = 4 for the cocaine groups). (C) The bar histograms depict the level of GluA1 divided by Actin, and rats treated with saline or cocaine with optic stimulation displayed significantly lower values compared with rats treated with saline or cocaine without optic stimulation ( p < 0.05), as determined by a two-way ANOVA test [F OPTIC STIMULATION (1,15) = 21.58, p < 0.001, F GROUP (1,15) = 0.1269, p > 0.05, F INTERACTION (1,15) = 0.1785, p > 0.05, followed by Tukey’s multiple comparison test]. ( n = 5, 4, 5, and 5 for saline -, saline +, cocaine-, and cocaine+ O.S. groups, respectively). (D) The bar histograms depict the level of GluA1ps845 divided by GluA1 antibodies, and no significant difference was found, as determined by a two-way ANOVA test [F OPTIC STIMULATION (1,10) = 2.936, p > 0.05, F GROUP (1,10) = 1.063, p > 0.05, F INTERACTION (1,10) = 0.00007179, p > 0.05, followed by Tukey’s multiple comparison test]. ( n = 3 for the saline groups, n = 4 for the cocaine groups). (E) The bar histograms depict the level of GluA1ps831 divided by GluA1 antibodies, and no significant difference was found, as determined by a two-way ANOVA test [F OPTIC STIMULATION (1,17) = 1.111, p > 0.05, F GROUP (1,17) = 0.8050, p > 0.05, F INTERACTION (1,17) = 0.7182, p > 0.05, followed by Tukey’s multiple comparison test]. ( n = 5, 4, 6, and 6 for saline -, saline +, cocaine-, and cocaine+ O.S. groups, respectively). (− O.S refers to - optic stimulation, whereas + O.S refers to + optic stimulation).

Journal: Frontiers in Molecular Neuroscience

Article Title: Activation of nucleus accumbens projections to the ventral tegmental area alters molecular signaling and neurotransmission in the reward system

doi: 10.3389/fnmol.2024.1271654

Figure Lengend Snippet: Enhanced GABAergic tone from the NAc during conditioning to saline or cocaine decreases GluA1 levels in the VTA. All rats were euthanized 45 min after the RePP test. Then, their VTA were taken out and homogenized. Samples were resolved by SDS-PAGE, and WB membranes were probed with the appropriate antibodies. (A) The bar histograms depict the level of ERK divided by Actin, and rats treated with cocaine (15 mg/kg) without optic stimulation, and rats treated with cocaine with optic stimulation displayed significantly lower values compared with the saline groups ( p < 0.05), as determined by a two-way ANOVA test [F OPTIC STIMULATION (1,10) = 5.746 , p < 0.05, F GROUP (1,10) = 45.24, p < 0.0001, F INTERACTION (1,10) = 0.8606, p > 0.05, followed by Tukey’s multiple comparison test]. ( n = 3 for the saline groups, n = 4 for the cocaine groups). (B) The bar histograms depict the level of pERK (Thr202/Tyr204) divided by ERK antibodies; no significant difference was found ( p > 0.05), as determined by a two-way ANOVA test [F OPTIC STIMULATION (1,10) = 1.515, p > 0.05, F GROUP (1,10) = 0.6789, p > 0.05, F INTERACTION (1,10) = 0.4926, p > 0.05, followed by Tukey’s multiple comparison test]. ( n = 3 for the saline groups, n = 4 for the cocaine groups). (C) The bar histograms depict the level of GluA1 divided by Actin, and rats treated with saline or cocaine with optic stimulation displayed significantly lower values compared with rats treated with saline or cocaine without optic stimulation ( p < 0.05), as determined by a two-way ANOVA test [F OPTIC STIMULATION (1,15) = 21.58, p < 0.001, F GROUP (1,15) = 0.1269, p > 0.05, F INTERACTION (1,15) = 0.1785, p > 0.05, followed by Tukey’s multiple comparison test]. ( n = 5, 4, 5, and 5 for saline -, saline +, cocaine-, and cocaine+ O.S. groups, respectively). (D) The bar histograms depict the level of GluA1ps845 divided by GluA1 antibodies, and no significant difference was found, as determined by a two-way ANOVA test [F OPTIC STIMULATION (1,10) = 2.936, p > 0.05, F GROUP (1,10) = 1.063, p > 0.05, F INTERACTION (1,10) = 0.00007179, p > 0.05, followed by Tukey’s multiple comparison test]. ( n = 3 for the saline groups, n = 4 for the cocaine groups). (E) The bar histograms depict the level of GluA1ps831 divided by GluA1 antibodies, and no significant difference was found, as determined by a two-way ANOVA test [F OPTIC STIMULATION (1,17) = 1.111, p > 0.05, F GROUP (1,17) = 0.8050, p > 0.05, F INTERACTION (1,17) = 0.7182, p > 0.05, followed by Tukey’s multiple comparison test]. ( n = 5, 4, 6, and 6 for saline -, saline +, cocaine-, and cocaine+ O.S. groups, respectively). (− O.S refers to - optic stimulation, whereas + O.S refers to + optic stimulation).

Article Snippet: The primary antibodies used in this study were Phospho ERK (Thr202/Tyr204) (cat. no. 91015; 1:1,500; Cell Signaling), ERK (cat. no. 9102 s; 1:1000; Cell Signaling), GluR1 (cat. no. AB1504; 1:2,000; Merck), Anti-phospho-GluR1 (Ser845) (cat. no. AB 5849; 1:500; Merck), Anti-phospho-GluR1 (Ser831) (cat. no. 04–823; 1:500; Merck), and Beta Actin (cat. no. ab8227; 1:7,000; Abcam).

Techniques: Saline, SDS Page, Comparison

Enhanced GABAergic tone from the NAc during conditioning to cocaine significantly increases ERK level and decreases GluA1ps845 and GluA1ps831 levels in the NAc. All rats were euthanized 45 min after the RePP test. Then, their NAc were taken out and homogenized. Samples were resolved by SDS-PAGE, and WB membranes were probed with the appropriate antibodies. (A) The bar histograms depict the level of ERK divided by Actin, rats treated with cocaine (15 mg/kg) with optic stimulation displayed significantly higher values compared with all other groups ( p < 0.05), as determined by a two-way ANOVA test [F OPTIC STIMULATION (1,10) = 6.563, p < 0.05, F GROUP (1,10) = 17.97, p < 0.01, F INTERACTION (1,10) = 7.29, p < 0.05, followed by Tukey’s multiple comparison test]. ( n = 3 for the saline groups, n = 4 for the cocaine groups). (B) The bar histograms depict the level of pERK (Thr202/Tyr204) divided by ERK antibodies; no significant difference was found ( p > 0.05), as determined by a two-way ANOVA test [F OPTIC STIMULATION (1,10) = 0.083, p > 0.05, F GROUP (1,10) = 0.6084, p > 0.05, F INTERACTION (1,10) = 0.0061, p > 0.05, followed by Tukey’s multiple comparison test]. ( n = 3 for the saline groups, n = 4 for the cocaine groups). (C) . The bar histograms depict the level of GluA1 divided by Actin, and no significant difference was found ( p > 0.05), as determined by a two-way ANOVA test [F OPTIC STIMULATION (1,16) = 2.382, p > 0.05, F GROUP (1,16) = 2.350, p > 0.05, F INTERACTION (1,16) = 0.1627, p > 0.05, followed by Tukey’s multiple comparison test]. ( n = 5, 4, 6, and 5 for saline -, saline +, cocaine-, and cocaine+ O.S. groups, respectively). (D) The bar histograms depict the level of GluA1ps845 divided by GluA1 antibodies, and rats treated with cocaine (15 mg/kg) with optic stimulation displayed significantly lower values compared with all other groups ( p < 0.05), as determined by a two-way ANOVA test [F OPTIC STIMULATION (1,9) = 2.472, p > 0.05, F GROUP (1,9) = 7.298, p < 0.05, F INTERACTION (1,9) = 14.07, p < 0.01, followed by Tukey’s multiple comparison test]. ( n = 3 for saline -, saline +, and cocaine - O.S. groups, n = 4 for cocaine + O.S. group, respectively). (E) The bar histograms depict the level of GluA1ps831 divided by GluA1 antibodies, and rats treated with cocaine (15 mg/kg) without optic stimulation and rats treated with cocaine with optic stimulation displayed significantly lower values compared with the saline groups ( p < 0.05), as determined by a two-way ANOVA test [F OPTIC STIMULATION (1,12) = 1.185, p > 0.05, F GROUP (1,12) = 27.96, p < 0.001, F INTERACTION (1,12) = 0.0002625, p > 0.05, followed by Tukey’s multiple comparison test]. ( n = 4 for all groups). (− O.S refers to - optic stimulation, whereas + O.S refers to + optic stimulation).

Journal: Frontiers in Molecular Neuroscience

Article Title: Activation of nucleus accumbens projections to the ventral tegmental area alters molecular signaling and neurotransmission in the reward system

doi: 10.3389/fnmol.2024.1271654

Figure Lengend Snippet: Enhanced GABAergic tone from the NAc during conditioning to cocaine significantly increases ERK level and decreases GluA1ps845 and GluA1ps831 levels in the NAc. All rats were euthanized 45 min after the RePP test. Then, their NAc were taken out and homogenized. Samples were resolved by SDS-PAGE, and WB membranes were probed with the appropriate antibodies. (A) The bar histograms depict the level of ERK divided by Actin, rats treated with cocaine (15 mg/kg) with optic stimulation displayed significantly higher values compared with all other groups ( p < 0.05), as determined by a two-way ANOVA test [F OPTIC STIMULATION (1,10) = 6.563, p < 0.05, F GROUP (1,10) = 17.97, p < 0.01, F INTERACTION (1,10) = 7.29, p < 0.05, followed by Tukey’s multiple comparison test]. ( n = 3 for the saline groups, n = 4 for the cocaine groups). (B) The bar histograms depict the level of pERK (Thr202/Tyr204) divided by ERK antibodies; no significant difference was found ( p > 0.05), as determined by a two-way ANOVA test [F OPTIC STIMULATION (1,10) = 0.083, p > 0.05, F GROUP (1,10) = 0.6084, p > 0.05, F INTERACTION (1,10) = 0.0061, p > 0.05, followed by Tukey’s multiple comparison test]. ( n = 3 for the saline groups, n = 4 for the cocaine groups). (C) . The bar histograms depict the level of GluA1 divided by Actin, and no significant difference was found ( p > 0.05), as determined by a two-way ANOVA test [F OPTIC STIMULATION (1,16) = 2.382, p > 0.05, F GROUP (1,16) = 2.350, p > 0.05, F INTERACTION (1,16) = 0.1627, p > 0.05, followed by Tukey’s multiple comparison test]. ( n = 5, 4, 6, and 5 for saline -, saline +, cocaine-, and cocaine+ O.S. groups, respectively). (D) The bar histograms depict the level of GluA1ps845 divided by GluA1 antibodies, and rats treated with cocaine (15 mg/kg) with optic stimulation displayed significantly lower values compared with all other groups ( p < 0.05), as determined by a two-way ANOVA test [F OPTIC STIMULATION (1,9) = 2.472, p > 0.05, F GROUP (1,9) = 7.298, p < 0.05, F INTERACTION (1,9) = 14.07, p < 0.01, followed by Tukey’s multiple comparison test]. ( n = 3 for saline -, saline +, and cocaine - O.S. groups, n = 4 for cocaine + O.S. group, respectively). (E) The bar histograms depict the level of GluA1ps831 divided by GluA1 antibodies, and rats treated with cocaine (15 mg/kg) without optic stimulation and rats treated with cocaine with optic stimulation displayed significantly lower values compared with the saline groups ( p < 0.05), as determined by a two-way ANOVA test [F OPTIC STIMULATION (1,12) = 1.185, p > 0.05, F GROUP (1,12) = 27.96, p < 0.001, F INTERACTION (1,12) = 0.0002625, p > 0.05, followed by Tukey’s multiple comparison test]. ( n = 4 for all groups). (− O.S refers to - optic stimulation, whereas + O.S refers to + optic stimulation).

Article Snippet: The primary antibodies used in this study were Phospho ERK (Thr202/Tyr204) (cat. no. 91015; 1:1,500; Cell Signaling), ERK (cat. no. 9102 s; 1:1000; Cell Signaling), GluR1 (cat. no. AB1504; 1:2,000; Merck), Anti-phospho-GluR1 (Ser845) (cat. no. AB 5849; 1:500; Merck), Anti-phospho-GluR1 (Ser831) (cat. no. 04–823; 1:500; Merck), and Beta Actin (cat. no. ab8227; 1:7,000; Abcam).

Techniques: SDS Page, Comparison, Saline

Enhanced GABAergic tone from the NAc during conditioning to cocaine significantly decreases ERK, GluA1, and GluA1ps831 levels, whereas it attenuates changes in GluA1ps845 in the mPFC. All rats were euthanized 45 min after the RePP test. Then, their mPFC were taken out and homogenized. Samples were resolved by SDS-PAGE, and WB membranes were probed with the appropriate antibodies. (A) The bar histograms depict the level of ERK divided by Actin, rats treated with cocaine (15 mg/kg) without optic stimulation and rats treated with cocaine with optic stimulation displayed significantly lower values compared with the saline control group ( p < 0.05), as determined by a two-way ANOVA test [F OPTIC STIMULATION (1,10) = 2.957, p > 0.05, F GROUP (1,10) = 28.78, p < 0.001, F INTERACTION (1,10) = 0.7083, p > 0.05, followed by Tukey’s multiple comparison test]. ( n = 3 for the saline groups, and n = 4 for the cocaine groups). (B) The bar histograms depict the level of pERK (Thr202/Tyr204) divided by ERK antibodies; no significant difference was found, as determined by a two-way ANOVA test [F OPTIC STIMULATION (1,10) = 3.882, p > 0.05, F GROUP (1,10) = 0.6174, p > 0.05, F INTERACTION (1,10) = 2.206, p > 0.05, followed by Tukey’s multiple comparison test]. ( n = 3 for the saline groups, and n = 4 for the cocaine groups). (C) The bar histograms depict the level of GluA1 divided by Actin, and rats treated with cocaine (15 mg/kg) without optic stimulation and rats treated with cocaine with optic stimulation displayed significantly lower values compared with the saline control group ( p < 0.05), as determined by a two-way ANOVA test [F OPTIC STIMULATION (1,10) = 5.238, p < 0.05, F GROUP (1,10) = 28.43, p < 0.001, F INTERACTION (1,10) = 0.3272, p > 0.05, followed by Tukey’s multiple comparison test]. ( n = 3 for the saline groups, and n = 4 for the cocaine groups). (D) The bar histograms depict the level of GluA1ps845 divided by GluA1 antibodies, and rats treated with cocaine (15 mg/kg) without optic stimulation displayed significantly lower values compared with all other groups ( p < 0.01), as determined by a two-way ANOVA test [F OPTIC STIMULATION (1,10) = 8.037, p < 0.05, F GROUP (1,10) = 11.26, p < 0.01, F INTERACTION (1,10) = 12.59, p < 0.01, followed by Tukey’s multiple comparison test]. ( n = 3 for the saline groups, and n = 4 for the cocaine groups). (E) The bar histograms depict the level of GluA1ps831 divided by GluA1 antibodies, and rats treated with cocaine (15 mg/kg) without optic stimulation displayed significantly lower values compared with the saline control group ( p < 0.01), and a similar effect was shown in the saline control group with optic stimulation and cocaine treated groups ( p < 0.01), as determined by a two-way ANOVA test [F OPTIC STIMULATION (1,10) = 6.92, p < 0.05, F GROUP (1,10) = 15.83, p < 0.01, F INTERACTION (1,10) = 20.12, p < 0.01, followed by Tukey’s multiple comparison test]. ( n = 3 for the saline groups, and n = 4 for the cocaine groups). (− O.S refers to - optic stimulation, whereas + O.S refers to + optic stimulation).

Journal: Frontiers in Molecular Neuroscience

Article Title: Activation of nucleus accumbens projections to the ventral tegmental area alters molecular signaling and neurotransmission in the reward system

doi: 10.3389/fnmol.2024.1271654

Figure Lengend Snippet: Enhanced GABAergic tone from the NAc during conditioning to cocaine significantly decreases ERK, GluA1, and GluA1ps831 levels, whereas it attenuates changes in GluA1ps845 in the mPFC. All rats were euthanized 45 min after the RePP test. Then, their mPFC were taken out and homogenized. Samples were resolved by SDS-PAGE, and WB membranes were probed with the appropriate antibodies. (A) The bar histograms depict the level of ERK divided by Actin, rats treated with cocaine (15 mg/kg) without optic stimulation and rats treated with cocaine with optic stimulation displayed significantly lower values compared with the saline control group ( p < 0.05), as determined by a two-way ANOVA test [F OPTIC STIMULATION (1,10) = 2.957, p > 0.05, F GROUP (1,10) = 28.78, p < 0.001, F INTERACTION (1,10) = 0.7083, p > 0.05, followed by Tukey’s multiple comparison test]. ( n = 3 for the saline groups, and n = 4 for the cocaine groups). (B) The bar histograms depict the level of pERK (Thr202/Tyr204) divided by ERK antibodies; no significant difference was found, as determined by a two-way ANOVA test [F OPTIC STIMULATION (1,10) = 3.882, p > 0.05, F GROUP (1,10) = 0.6174, p > 0.05, F INTERACTION (1,10) = 2.206, p > 0.05, followed by Tukey’s multiple comparison test]. ( n = 3 for the saline groups, and n = 4 for the cocaine groups). (C) The bar histograms depict the level of GluA1 divided by Actin, and rats treated with cocaine (15 mg/kg) without optic stimulation and rats treated with cocaine with optic stimulation displayed significantly lower values compared with the saline control group ( p < 0.05), as determined by a two-way ANOVA test [F OPTIC STIMULATION (1,10) = 5.238, p < 0.05, F GROUP (1,10) = 28.43, p < 0.001, F INTERACTION (1,10) = 0.3272, p > 0.05, followed by Tukey’s multiple comparison test]. ( n = 3 for the saline groups, and n = 4 for the cocaine groups). (D) The bar histograms depict the level of GluA1ps845 divided by GluA1 antibodies, and rats treated with cocaine (15 mg/kg) without optic stimulation displayed significantly lower values compared with all other groups ( p < 0.01), as determined by a two-way ANOVA test [F OPTIC STIMULATION (1,10) = 8.037, p < 0.05, F GROUP (1,10) = 11.26, p < 0.01, F INTERACTION (1,10) = 12.59, p < 0.01, followed by Tukey’s multiple comparison test]. ( n = 3 for the saline groups, and n = 4 for the cocaine groups). (E) The bar histograms depict the level of GluA1ps831 divided by GluA1 antibodies, and rats treated with cocaine (15 mg/kg) without optic stimulation displayed significantly lower values compared with the saline control group ( p < 0.01), and a similar effect was shown in the saline control group with optic stimulation and cocaine treated groups ( p < 0.01), as determined by a two-way ANOVA test [F OPTIC STIMULATION (1,10) = 6.92, p < 0.05, F GROUP (1,10) = 15.83, p < 0.01, F INTERACTION (1,10) = 20.12, p < 0.01, followed by Tukey’s multiple comparison test]. ( n = 3 for the saline groups, and n = 4 for the cocaine groups). (− O.S refers to - optic stimulation, whereas + O.S refers to + optic stimulation).

Article Snippet: The primary antibodies used in this study were Phospho ERK (Thr202/Tyr204) (cat. no. 91015; 1:1,500; Cell Signaling), ERK (cat. no. 9102 s; 1:1000; Cell Signaling), GluR1 (cat. no. AB1504; 1:2,000; Merck), Anti-phospho-GluR1 (Ser845) (cat. no. AB 5849; 1:500; Merck), Anti-phospho-GluR1 (Ser831) (cat. no. 04–823; 1:500; Merck), and Beta Actin (cat. no. ab8227; 1:7,000; Abcam).

Techniques: SDS Page, Saline, Comparison